Shares of Biogen Inc. BIIB slipped 1.40% to $138.37 Friday, on what proved to be an all-around rough trading session for the ...

Rebranding efforts include a new logo, overall brand presence, and corporate design.

Biogen Inc. investors can advance their claim that the company misrepresented clinical trial data for its Alzheimer’s drug, a federal judge ruled.

The label organic — which in Maine can be denoted by either the USDA or MOFGA — is consistent across the country, and means ...

Biogen Inc. closed 41.04% below its 52-week high of $238.00, which the company achieved on July 12th.

Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

The Stoic Cider rebranding includes a refreshed visual identity and innovative can packaging to elevates Stoic’s presence in ...

Biogen Inc. has a 12-month low of $128.51 and a 12-month high of $238.00. The stock has a market cap of $20.41 billion, a price-to-earnings ratio of 12.46, a PEG ratio of 1.51 and a beta of 0.01.

The South Korean carrier presented a Boeing 787-10 with its new logo featuring a blue taegeuk symbol at a press event in Seoul Tuesday, the airline’s first design change since 1984.

March 11, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the efficacy and ...

I'm Marc Goodman, one of the biopharma analyst, and we're lucky to have Biogen with us here, Alisha Alaimo, who is the President of North America. Thank you very much for joining us. Well ...

Investors with a lot of money to spend have taken a bullish stance on Biogen (NASDAQ:BIIB). And retail traders should know. We noticed this today when the trades showed up on publicly available ...